Skip to content

Ironwood Pharmaceuticals IRWD Total Cost of Revenue

Discontinued — last reported Q4 '20

Total Cost of Revenue at other companies

Bausch Health Companies logo
Bausch Health CompaniesBHC
$584M-8.0%
Ardelyx logo
ArdelyxARDX
$4.81M-60.9%
Eton Pharmaceuticals, Inc. logo
Eton Pharmaceuticals, Inc.ETON
$9.53M+28.4%
Rigel Pharmaceuticals logo
Rigel PharmaceuticalsRIGL
$4.61M+4.5%
ANI Pharmaceuticals logo
ANI PharmaceuticalsANIP
$93.58M+28.1%
Catalyst Pharmaceutical logo
Catalyst PharmaceuticalCPRX
$14.48M-19.2%

Other financials

Income statement

See full
Revenue$106.5M+159%
Operating income$72.6M+349%
Net income$40.8M+209%
EPS (diluted)$0.24+204%

Balance sheet

See full
Cash & equivalents$220.5M+103%
Total debt$212.4M+1,323%
Total equity-$217.1M+35.0%
Total assets$434.6M+32.8%

Cash flow

See full
Operating cash flow$5.1M-74.3%
CapEx-
Free cash flow$74.6M+390%

Valuation

See full
Market cap$632.12M+457%
Enterprise value$624M+3,024%
P/E6.2×
P/S1.8×+1.4×

Profitability

See full
Gross margin99.2%
Operating margin55.4%+38.7pp
Net margin28.3%+22.3pp
FCF margin24.7%-11.1pp

Returns & leverage

See full
Return on equity29.7%-138pp
Debt / equity-0.5×
Current ratio1.4×-1.9×

Where this comes from

Reported directly by Ironwood Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:CostOfGoodsAndServicesSold.

The official record: Ironwood Pharmaceuticals’s 10-K, filed February 16, 2023, on SEC EDGAR. View the filing →

Questions, answered.

What does total cost of revenue mean?
The aggregate of all direct costs attributable to producing goods and delivering services that generated the company's revenue, including materials, labor, and overhead.